Pacific Edge Limited (PFGTF)
USD 0.08
(1.27%)
USD 0.08
(1.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -25.18 Million NZD | 67.1% |
| 2023 | -20.02 Million NZD | 13.73% |
| 2022 | -23.21 Million NZD | -2549.65% |
| 2021 | -876.13 Thousand NZD | -635.24% |
| 2020 | -119.16 Thousand NZD | 97.58% |
| 2019 | -4.92 Million USD | 7.02% |
| 2018 | -5.3 Million USD | 21.18% |
| 2017 | -6.72 Million USD | -124.38% |
| 2016 | -2.99 Million USD | -41.87% |
| 2015 | -2.11 Million NZD | 50.76% |
| 2014 | -4.29 Million NZD | 20.85% |
| 2013 | -5.42 Million NZD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -16.71 Million USD | -38.81% |
| 2024 Q4 | -50.62 Million USD | 4.78% |
| 2024 Q1 | -12.02 Million USD | 74.42% |
| 2024 FY | -25.18 Million NZD | -25.77% |
| 2024 Q2 | -11.73 Million USD | 2.7% |
| 2023 Q3 | -20.83 Million USD | 0.19% |
| 2023 FY | -20.02 Million NZD | 13.73% |
| 2023 Q4 | -20.02 Million NZD | 3.9% |
| 2023 Q2 | -20.87 Million USD | 0.0% |
| 2022 FY | -23.21 Million NZD | -2549.65% |
| 2022 Q2 | -53.62 Million USD | 0.0% |
| 2022 Q4 | -23.21 Million USD | 0.0% |
| 2021 Q4 | -876.13 Thousand USD | 0.0% |
| 2021 FY | -876.13 Thousand NZD | -635.24% |
| 2021 Q2 | -1.25 Million USD | 0.0% |
| 2020 Q4 | -119.16 Thousand USD | 0.0% |
| 2020 FY | -119.16 Thousand NZD | 97.58% |
| 2020 Q2 | -775.03 Thousand USD | 0.0% |
| 2019 FY | -4.92 Million USD | 7.02% |
| 2018 FY | -5.3 Million USD | 21.18% |
| 2017 FY | -6.72 Million USD | -124.38% |
| 2016 FY | -2.99 Million USD | -41.87% |
| 2015 FY | -2.11 Million NZD | 50.76% |
| 2014 FY | -4.29 Million NZD | 20.85% |
| 2013 FY | -5.42 Million NZD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 1241.795% |
| Arrayit Corporation | 1.05 Million USD | 2486.176% |
| Atlantic International Corp. | 236.49 Thousand USD | 10750.497% |
| Biocept, Inc. | -788 Thousand USD | -3096.447% |
| Bioqual, Inc. | -12 Million USD | -109.776% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 110870.043% |
| DermTech, Inc. | 17.65 Million USD | 242.684% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 95.6% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | -241.444% |
| iMD Companies, Inc. | 1.11 Million USD | 2357.163% |
| IDenta Corp. | 524.85 Thousand USD | 4899.067% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 427.372% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | -93355.031% |
| InVitro International | -313.14 Thousand USD | -7943.635% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 1708.517% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -3532578.822% |
| Medical Imaging Corp. | 3.79 Million USD | 764.427% |
| NovelStem International Corp. | 3.52 Million USD | 815.256% |
| Optigenex Inc. | 8.93 Million USD | 381.935% |
| PharmChem, Inc. | -1.49 Million USD | -1585.478% |
| Proteome Sciences plc | 14.57 Million USD | 272.837% |
| Response Genetics, Inc | -13.08 Million USD | -92.481% |
| Rennova Health, Inc. | 14.82 Million USD | 269.846% |
| RushNet, Inc. | 4.8 Million USD | 624.658% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 18676.728% |
| Stella Diagnostics Inc. | 6.19 Million USD | 506.713% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 1511.568% |
| Todos Medical Ltd. | 38.31 Million USD | 165.741% |